Business Description
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Business History
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -5.96
Total Equity: $235.58M
Shares: 16,047,452
Total Debt: $0.00
Cash: $182.33M
EBITDA: -$60.57M
Total Debt: $0.00
Cash: $182.33M
Revenue: $249.33M
Shares: 16,047,452
Revenue: $249.33M
Revenue: $249.33M
Revenue: $249.33M
Total Equity: $235.58M
Tax Rate: -0.5%
Equity: $235.58M
Total Debt: $0.00
Cash: $182.33M
Current Liabilities: $73.21M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $235.58M
Shares: 16,047,452
Shares: 16,047,452
CapEx: -$21,000
Shares: 16,047,452
Stock Price: $9.19
Net Income: -$95.70M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 21, 2026 7:44pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $252.8M | $277.2M | $259.0M | $254.4M | $249.3M |
| Cost of Revenue | $148.5M | $160.4M | $164.3M | $155.4M | $116.5M |
| Gross Profit | $104.3M | $116.8M | $94.8M | $99.0M | $132.9M |
| Operating Expenses | $283.5M | $392.6M | $786.9M | $316.5M | $238.1M |
| Operating Income | -$179.1M | -$275.9M | -$692.1M | -$217.5M | -$105.3M |
| Net Income | -$176.3M | -$270.4M | -$675.2M | -$208.1M | -$95.7M |
| EBITDA | -$166.1M | -$245.8M | -$224.2M | -$176.9M | -$60.6M |
| EPS | $-13.88 | $-19.68 | $-47.50 | $-13.88 | $-5.96 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 7:44pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $746.4M | $538.5M | $372.0M | $228.3M | $182.3M |
| Total Current Assets | $827.3M | $626.6M | $449.6M | $317.0M | $246.7M |
| Total Assets | $1.4B | $1.2B | $589.7M | $436.0M | $323.8M |
| Current Liabilities | $141.6M | $114.1M | $93.8M | $111.3M | $73.2M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $185.0M | $133.7M | $109.5M | $119.7M | $76.0M |
| Total Equity | $1.2B | $1.1B | $464.2M | $304.8M | $235.6M |
| Retained Earnings | -$811.3M | -$1.1B | -$1.8B | -$2.0B | -$2.1B |
Cash Flow (Annual)
Last updated: Jun 21, 2026 7:44pm (5d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$141.5M | -$192.3M | -$148.3M | -$127.3M | -$66.0M |
| Capital Expenditure | $-559,000 | -$10.4M | -$15.2M | -$15.2M | $-21,000 |
| Free Cash Flow | -$142.1M | -$202.8M | -$163.6M | -$142.6M | -$66.0M |
| Acquisitions (net) | -$159.1M | -$2.0M | $0 | -$3.4M | $18.3M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$15.0M | $-360,000 | $-586,000 | $-3,000 | $-4,000 |
| Net Change in Cash | -$195.5M | -$207.9M | -$166.5M | -$143.7M | -$46.0M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 3:30am (5h ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$208.6M $202.6M – $214.7M
|
$217.8M $217.8M – $217.8M
|
$220.2M $215.1M – $227.3M
|
$232.0M $226.6M – $239.4M
|
| EBITDA |
-$139.7M -$143.7M – -$135.7M
|
-$145.8M -$145.8M – -$145.8M
|
-$147.4M -$152.2M – -$144.0M
|
-$155.3M -$160.3M – -$151.7M
|
| Net Income |
-$36.5M -$37.8M – -$35.2M
|
-$18.3M -$19.8M – -$16.9M
|
-$4.7M -$4.9M – -$4.6M
|
$1.5M $1.5M – $1.6M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 7:44pm (5d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +9.7% | -6.5% | -1.8% | -2.0% |
| Gross Profit Growth | +11.9% | -18.8% | +4.4% | +34.3% |
| Operating Income Growth | -54.0% | -150.9% | +68.6% | +51.6% |
| Net Income Growth | -53.4% | -149.7% | +69.2% | +54.0% |
| EBITDA Growth | -48.0% | +8.8% | +21.1% | +65.8% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 3:30am (5h ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-16 | Cosgrove Delos M. | A-Award | 14,501.00 | $0.00 | $0 |
| 2026-06-16 | Webb Robert Thomas | A-Award | 14,501.00 | $0.00 | $0 |
| 2026-06-16 | Ross Derek | A-Award | 14,501.00 | $0.00 | $0 |
| 2026-06-16 | Goldwasser Rivka | A-Award | 14,501.00 | $0.00 | $0 |
| 2026-06-16 | Schlegel Stephen J. | A-Award | 14,501.00 | $0.00 | $0 |
| 2026-06-16 | Jackson Deborah C | A-Award | 14,501.00 | $0.00 | $0 |
| 2026-06-11 | Schlegel Stephen J. | S-Sale | 9,750.00 | $8.76 | $85,449 |
| 2026-05-07 | Schoenberg Ido | P-Purchase | 670.00 | $7.37 | $4,938 |
| 2026-04-01 | Gotlib Phyllis | S-Sale | 3,706.00 | $5.30 | $19,642 |
| 2026-04-01 | Zamansky Dmitry | S-Sale | 5,575.00 | $5.30 | $29,548 |
| 2026-04-01 | McNeice Paul Francis | S-Sale | 383.00 | $5.30 | $2,030 |
| 2026-03-04 | HIRSCHHORN MARK | A-Award | 50,413.00 | $0.00 | $0 |
| 2026-03-04 | Gotlib Phyllis | A-Award | 50,413.00 | $0.00 | $0 |
| 2026-03-04 | Zamansky Dmitry | A-Award | 50,413.00 | $0.00 | $0 |
| 2026-03-04 | McNeice Paul Francis | A-Award | 8,066.00 | $0.00 | $0 |
| 2026-03-02 | Zamansky Dmitry | S-Sale | 2,472.00 | $5.45 | $13,472 |
| 2026-03-02 | HIRSCHHORN MARK | S-Sale | 10,796.00 | $5.24 | $56,571 |
| 2026-03-02 | Gotlib Phyllis | S-Sale | 3,573.00 | $5.24 | $18,723 |
| 2026-03-02 | McNeice Paul Francis | S-Sale | 130.00 | $5.24 | $681 |
| 2026-01-02 | Zamansky Dmitry | S-Sale | 6,243.00 | $4.85 | $30,279 |
Narrative Economics
market-narrative step).